Clinical Trials Browser

Terminated × INDUSTRY × Immunoconjugates × Clear all

NCT01605318 2024-01-24

Study of Labetuzumab Govitecan in Participants With Metastatic Colorectal Cancer

Phase 1/2 Terminated

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms